oral semaglutide news Lowers HbA1c in Phase 3 Trial in Youth With Type 2 Diabetes Oral Semaglutide Did Not Confirm
Description
It has just completed a phase 2 trial and will soon enter the phase 3 trial to confirm its efficacy further

That's not just significant

If you also take the blood thinner warfarin, you may have a higher risk of uncontrolled bleeding

Double and Triple Incretin-Receptor Agonist Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, has demonstrated superiority compared with GLP1-RA on both glycemic control and weight loss, and achieved favorable effects on hepatic endpoints

If you develop symptoms like a lump in your neck, hoarseness, or trouble swallowing, you should contact your doctor right away

Schwartz, G.J
